In this study, we evaluated the role of CDK7 in regulating the angiogenic activity of human umbilical vascular endothelial cells (HUVECs), as well as the antiangiogenic and antitumor effects of THZ1 on RCC cells. The gene discussed is CDK7; the disease is renal cell carcinoma.